Global Single-Cell Genome Sequencing Market, By Type (Instruments and Reagents), Technology (NGS, PCR, Q-PCR, Microarray, and MDA), Workflow (Single Cell Isolation, Sample Preparation, and Genomic Analysis), Disease Area (Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, and Others), Application (Circulating Cells, Cell Differentiation, Genomic Variation, Subpopulation Characterization, and Others), End User (Academic and Research Laboratories, Biotechnology and Biopharmaceutical Companies, Clinics and Others) – Industry Trends and Forecast to 2030.
Single-Cell Genome Sequencing Market Analysis and Size
Increasing chronic diseases such as cancer and diabetes will boost the growth in the demand for single-cell genome sequencing. The collaboration among the market players and several research institutes for the research and development of the latest advanced diagnostics and treatment methods with the help of the sequencing method is also enhancing the market's growth. It has been witnessed that the PCR segment is expected to hold a major market share in the market over the forecast period.
Data Bridge Market Research analyses that the single-cell genome sequencing market, which was USD 2 billion in 2022, would rise up to USD 5.71 billion by 2030 and is expected to undergo a CAGR of 14% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Single-Cell Genome Sequencing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Instruments and Reagents), Technology (NGS, PCR, Q-PCR, Microarray and MDA), Workflow (Single Cell Isolation, Sample Preparation and Genomic Analysis), Disease Area (Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology and Others), Application (Circulating Cells, Cell Differentiation, Genomic Variation, Subpopulation Characterization and Others), End User (Academic and Research Laboratories, Biotechnology and Biopharmaceutical Companies, Clinics and Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Oxford Nanopore Technologies plc (U.K.)., PacBio (U.S.), Novogene Co, Ltd (China).., Mission Bio (U.S)., Fluxion Biosciences Inc (U.S.)., Thermo Fisher Scientific (U.S.), QIAGEN (Netherlands), Agilent Technologies, Inc. (U.S.), McKesson Corporation (U.S), Allscripts Healthcare, LLC, (U.S), Siemens, (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), and BGI (China), B.D. (U.S.), Danaher (U.S.), Bruker (U.S.), 10x Genomics (U.S.), Promega Corporation (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Single-cell genome sequencing is a well-elaborated procedure of isolating, amplifying, and sequencing genes within that single cell. Single-cell genome sequencing utilizes next-generation sequencing technology that assists in understanding the functioning of a cell. Single-cell genome sequencing is an advanced technology that helps to show the biological processes and illustrate organisms that are difficult to culture in vitro. This process is widely used in neurology, immunology, and cancer research.
Global Single-Cell Genome Sequencing Market Dynamics
Drivers
- Increasing Product Launches by Market Players
Several product launches by major market players lead to the market's growth. For instance, Stilla Technologies launched one of the world's first six-color digital PCR instruments known as 'the six-color Prism' in 2020. This system can be used extensively in infectious disease, oncology, gene therapy, disease monitoring, and food testing. Likewise, Bio-Rad launched CFX Opus Deepwell real-time PCR detection system in 2022. Bio-Rad's CFx Opus Deepwell Real-time PCR Detection system will help researchers in developing nucleic acid detection assays. This factor leads to the growth of the market.
- Increasing Prevalence of Cancer
As per the American Cancer Society, cancer is the second most common cause of mortality in the U.S. As per the cancer statistics, in 2022, around 1.9 million new cancer cases are anticipated to occur in the U.S. As per the data by Globocan 2020, the country's estimated number of new cancer cases in 2020 was 195,449. This increasing incidence of cancer is demanding more and more studies and experiments, which are further demanding the use of genome sequencing. Thus, this factor boosts the market growth.
Opportunities
- Increasing Collaborations by Market Players For Higher R&D Activities
The collaboration among the major market players and research institutes for the research and development of several new diagnostics and treatment methods with the help of the sequencing method is also increasing the market's growth. For instance, Illumina and Israel-based Danyel Biotech stated that scientists at the Weizmann Institute of Science in Israel are now using Illumina's next-generation sequencing (NGS) technology in 2020. Thus, this factor boosts market growth.
- Increased Funding for Drug Development Processes
Increasing funding by organizations for advanced genome sequencing instruments is boosting the market growth. For instance, according to the article ' United States Tax Dollars Funded Every New Pharmaceutical in the Last Decade' published in 2020, around USD 230 Billion were received by NIH to develop drugs and targets. Such funding in the biotechnology field surges the research and the usage of PCR devices, increasing market growth. Thus, this factor boosts market growth.
Restraints/Challenges
- High Cost of Genomic Sequencing Instruments
The high cost of genome sequencing instruments leads to market hindrances as it cannot be appointed by many underdeveloped nations' hospitals and research institutes. Also, a lot of maintenance is required to keep the consistency good. Thus, this factor impedes market growth.
This single-cell genome sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the single-cell genome sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Single- Cell Genome Sequencing Market Scope
The single-cell genome sequencing market is segmented on the basis of type, technology, workflow, disease area, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Instruments
- Reagents
Technology
- NGS
- PCR
- Q-PCR
- Microarray
- MDA
Workflow
- Single Cell Isolation
- Sample Preparation
- Genomic Analysis
Disease Area
- Cancer
- Immunology
- Prenatal Diagnosis
- Neurobiology
- Microbiology
- Others
Application
- Circulating Cells
- Cell Differentiation
- Genomic Variation
- Subpopulation Characterization
- Others
End User
- Academic and Research Laboratories
- Biotechnology and Biopharmaceutical Companies
- Clinics
- Others
Single- Cell Genome Sequencing Market Regional Analysis/Insights
The single-cell genome sequencing market is analyzed and market size insights and trends are provided by type, technology, workflow, disease area, application and end user as referenced above.
The countries covered in the single-cell genome sequencing market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the single-cell genome sequencing market because of the increased funding for research and development proficiencies and increased adoption of genomic analysis products. Also, the major players associated with this market are boosting the growth of the market.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period due to the increase in patients suffering from chronic ailments and advanced healthcare infrastructure, particularly in developing countries, that will induce market growth in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The single-cell genome sequencing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for single-cell genome sequencing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the single-cell genome sequencing market. The data is available for historic period 2011-2021.
Competitive Landscape and Single- Cell Genome Sequencing Market Share Analysis
The single-cell genome sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to single-cell genome sequencing market.
Some of the major players operating in the single-cell genome sequencing market are:
- Oxford Nanopore Technologies plc (U.K.)
- PacBio (U.S.
- Novogene Co, Ltd (China)
- Mission Bio (U.S).
- Fluxion Biosciences Inc (U.S.)
- Thermo Fisher Scientific (U.S.)
- QIAGEN (Netherlands)
- Agilent Technologies, Inc. (U.S.)
- McKesson Corporation (U.S)
- Allscripts Healthcare, LLC, (U.S
- Siemens, (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bio-Rad Laboratories, Inc. (U.S.)
- BGI (China)
- B.D. (U.S.)
- Danaher (U.S.)
- Bruker (U.S.)
- 10x Genomics (U.S.)
- Promega Corporation (U.S.)
SKU-